EDAP TMS SA -ADR (EDAP) Fundamental Analysis & Valuation

NASDAQ:EDAP • US2683111072

Current stock price

3.325 USD
+0.03 (+0.76%)
At close:
3.37 USD
+0.04 (+1.35%)
After Hours:

This EDAP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. EDAP Profitability Analysis

1.1 Basic Checks

  • In the past year EDAP has reported negative net income.
  • In the past year EDAP has reported a negative cash flow from operations.
  • EDAP had negative earnings in 4 of the past 5 years.
  • In the past 5 years EDAP reported 4 times negative operating cash flow.
EDAP Yearly Net Income VS EBIT VS OCF VS FCFEDAP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

  • With a Return On Assets value of -31.94%, EDAP is not doing good in the industry: 60.11% of the companies in the same industry are doing better.
  • Looking at the Return On Equity, with a value of -84.17%, EDAP is doing worse than 61.70% of the companies in the same industry.
Industry RankSector Rank
ROA -31.94%
ROE -84.17%
ROIC N/A
ROA(3y)-16.04%
ROA(5y)-10.06%
ROE(3y)-29.27%
ROE(5y)-18.58%
ROIC(3y)N/A
ROIC(5y)N/A
EDAP Yearly ROA, ROE, ROICEDAP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

  • With a Gross Margin value of 43.24%, EDAP is not doing good in the industry: 63.83% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of EDAP has declined.
  • EDAP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-2.4%
EDAP Yearly Profit, Operating, Gross MarginsEDAP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

2

2. EDAP Health Analysis

2.1 Basic Checks

  • EDAP does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • EDAP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EDAP Yearly Shares OutstandingEDAP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
EDAP Yearly Total Debt VS Total AssetsEDAP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • A Debt/Equity ratio of 0.26 indicates that EDAP is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.26, EDAP is in line with its industry, outperforming 54.26% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC7.66%
EDAP Yearly LT Debt VS Equity VS FCFEDAP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • EDAP has a Current Ratio of 1.41. This is a normal value and indicates that EDAP is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of EDAP (1.41) is worse than 80.32% of its industry peers.
  • A Quick Ratio of 0.97 indicates that EDAP may have some problems paying its short term obligations.
  • The Quick ratio of EDAP (0.97) is worse than 82.98% of its industry peers.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 0.97
EDAP Yearly Current Assets VS Current LiabilitesEDAP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

3

3. EDAP Growth Analysis

3.1 Past

  • EDAP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.00%.
EPS 1Y (TTM)-38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-340%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-6.8%

3.2 Future

  • EDAP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.79% yearly.
  • EDAP is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.69% yearly.
EPS Next Y4.86%
EPS Next 2Y12.53%
EPS Next 3Y10.91%
EPS Next 5Y18.79%
Revenue Next Year5.81%
Revenue Next 2Y3.17%
Revenue Next 3Y1.16%
Revenue Next 5Y23.69%

3.3 Evolution

EDAP Yearly Revenue VS EstimatesEDAP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
EDAP Yearly EPS VS EstimatesEDAP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5

0

4. EDAP Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for EDAP. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EDAP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EDAP Price Earnings VS Forward Price EarningsEDAP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EDAP Per share dataEDAP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.53%
EPS Next 3Y10.91%

0

5. EDAP Dividend Analysis

5.1 Amount

  • No dividends for EDAP!.
Industry RankSector Rank
Dividend Yield 0%

EDAP Fundamentals: All Metrics, Ratios and Statistics

EDAP TMS SA -ADR

NASDAQ:EDAP (4/13/2026, 4:30:02 PM)

After market: 3.37 +0.04 (+1.35%)

3.325

+0.03 (+0.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-25
Earnings (Next)05-13
Inst Owners38.98%
Inst Owner Change0%
Ins Owners4.41%
Ins Owner Change0%
Market Cap124.63M
Revenue(TTM)N/A
Net Income(TTM)-19.63M
Analysts77.78
Price Target6.97 (109.62%)
Short Float %0.13%
Short Ratio0.7
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.42%
Min EPS beat(2)7.96%
Max EPS beat(2)40.88%
EPS beat(4)3
Avg EPS beat(4)19.08%
Min EPS beat(4)-23.38%
Max EPS beat(4)50.84%
EPS beat(8)3
Avg EPS beat(8)-24.52%
EPS beat(12)3
Avg EPS beat(12)-303.5%
EPS beat(16)7
Avg EPS beat(16)-180.95%
Revenue beat(2)2
Avg Revenue beat(2)5.63%
Min Revenue beat(2)5.32%
Max Revenue beat(2)5.94%
Revenue beat(4)3
Avg Revenue beat(4)0.41%
Min Revenue beat(4)-12.67%
Max Revenue beat(4)5.94%
Revenue beat(8)4
Avg Revenue beat(8)-1.45%
Revenue beat(12)5
Avg Revenue beat(12)-3.55%
Revenue beat(16)7
Avg Revenue beat(16)-1.94%
PT rev (1m)0%
PT rev (3m)17.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.11%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.36%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.61%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.67
P/FCF N/A
P/OCF N/A
P/B 4.56
P/tB 5.09
EV/EBITDA N/A
EPS(TTM)-0.81
EYN/A
EPS(NY)-0.77
Fwd EYN/A
FCF(TTM)-0.51
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS1.99
BVpS0.73
TBVpS0.65
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -31.94%
ROE -84.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.24%
FCFM N/A
ROA(3y)-16.04%
ROA(5y)-10.06%
ROE(3y)-29.27%
ROE(5y)-18.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-2.4%
F-Score4
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 189.75%
Cap/Sales 7.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 0.97
Altman-Z N/A
F-Score4
WACC7.66%
ROIC/WACCN/A
Cap/Depr(3y)176.18%
Cap/Depr(5y)116.88%
Cap/Sales(3y)5.91%
Cap/Sales(5y)4.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-340%
EPS Next Y4.86%
EPS Next 2Y12.53%
EPS Next 3Y10.91%
EPS Next 5Y18.79%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-6.8%
Revenue Next Year5.81%
Revenue Next 2Y3.17%
Revenue Next 3Y1.16%
Revenue Next 5Y23.69%
EBIT growth 1Y-0.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year13.69%
EBIT Next 3Y-0.57%
EBIT Next 5Y4.36%
FCF growth 1Y6.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.45%
OCF growth 3YN/A
OCF growth 5YN/A

EDAP TMS SA -ADR / EDAP Fundamental Analysis FAQ

What is the fundamental rating for EDAP stock?

ChartMill assigns a fundamental rating of 1 / 10 to EDAP.


Can you provide the valuation status for EDAP TMS SA -ADR?

ChartMill assigns a valuation rating of 0 / 10 to EDAP TMS SA -ADR (EDAP). This can be considered as Overvalued.


What is the profitability of EDAP stock?

EDAP TMS SA -ADR (EDAP) has a profitability rating of 0 / 10.